177 related articles for article (PubMed ID: 25048928)
1. Estrogenic and androgenic activities of TBBA and TBMEPH, metabolites of novel brominated flame retardants, and selected bisphenols, using the XenoScreen XL YES/YAS assay.
Fic A; Žegura B; Gramec D; Mašič LP
Chemosphere; 2014 Oct; 112():362-9. PubMed ID: 25048928
[TBL] [Abstract][Full Text] [Related]
2. Comparison of in vitro hormone activities of novel flame retardants TBB, TBPH and their metabolites TBBA and TBMEPH using reporter gene assays.
Klopčič I; Skledar DG; Mašič LP; Dolenc MS
Chemosphere; 2016 Oct; 160():244-51. PubMed ID: 27380226
[TBL] [Abstract][Full Text] [Related]
3. Hormonal activities of new brominated flame retardants.
Ezechiáš M; Svobodová K; Cajthaml T
Chemosphere; 2012 May; 87(7):820-4. PubMed ID: 22236593
[TBL] [Abstract][Full Text] [Related]
4. Characterization of estrogenic and androgenic activity of phthalates by the XenoScreen YES/YAS in vitro assay.
Czernych R; Chraniuk M; Zagożdżon P; Wolska L
Environ Toxicol Pharmacol; 2017 Jul; 53():95-104. PubMed ID: 28528305
[TBL] [Abstract][Full Text] [Related]
5. In vitro metabolism of the brominated flame retardants 2-ethylhexyl-2,3,4,5-tetrabromobenzoate (TBB) and bis(2-ethylhexyl) 2,3,4,5-tetrabromophthalate (TBPH) in human and rat tissues.
Roberts SC; Macaulay LJ; Stapleton HM
Chem Res Toxicol; 2012 Jul; 25(7):1435-41. PubMed ID: 22575079
[TBL] [Abstract][Full Text] [Related]
6. New brominated flame retardants and their metabolites as activators of the pregnane X receptor.
Gramec Skledar D; Tomašič T; Carino A; Distrutti E; Fiorucci S; Peterlin Mašič L
Toxicol Lett; 2016 Sep; 259():116-123. PubMed ID: 27506419
[TBL] [Abstract][Full Text] [Related]
7. In vitro endocrine disruption and TCDD-like effects of three novel brominated flame retardants: TBPH, TBB, & TBCO.
Saunders DM; Higley EB; Hecker M; Mankidy R; Giesy JP
Toxicol Lett; 2013 Nov; 223(2):252-9. PubMed ID: 24064184
[TBL] [Abstract][Full Text] [Related]
8. The Effects of Mono-(2-Ethylhexyl) Phthalate (MEHP) on Human Estrogen Receptor (hER) and Androgen Receptor (hAR) by YES/YAS In Vitro Assay.
Kim DH; Park CG; Kim SH; Kim YJ
Molecules; 2019 Apr; 24(8):. PubMed ID: 31010227
[TBL] [Abstract][Full Text] [Related]
9. BPA, BADGE and analogues: A new multi-analyte LC-ESI-MS/MS method for their determination and their in vitro (anti)estrogenic and (anti)androgenic properties.
van Leeuwen SP; Bovee TF; Awchi M; Klijnstra MD; Hamers AR; Hoogenboom RL; Portier L; Gerssen A
Chemosphere; 2019 Apr; 221():246-253. PubMed ID: 30640007
[TBL] [Abstract][Full Text] [Related]
10. Bisphenols (A, S, and F) affect the basic hormonal activity determined for pharmaceuticals - Study of Saccharomyces cerevisiae.
Kudłak B; Wieczerzak M; Namieśnik J
Environ Pollut; 2019 Mar; 246():914-920. PubMed ID: 31159141
[TBL] [Abstract][Full Text] [Related]
11. Effects of novel brominated flame retardants and metabolites on cytotoxicity in human umbilical vein endothelial cells.
Chen Y; Guo M; Liu R; Ma LQ; Cui X
Chemosphere; 2020 Aug; 253():126653. PubMed ID: 32302898
[TBL] [Abstract][Full Text] [Related]
12. Endocrine disrupting activities and immunomodulatory effects in lymphoblastoid cell lines of diclofenac, 4-hydroxydiclofenac and paracetamol.
Klopčič I; Markovič T; Mlinarič-Raščan I; Sollner Dolenc M
Toxicol Lett; 2018 Sep; 294():95-104. PubMed ID: 29777833
[TBL] [Abstract][Full Text] [Related]
13. In house validation of recombinant yeast estrogen and androgen receptor agonist and antagonist screening assays.
Kolle SN; Kamp HG; Huener HA; Knickel J; Verlohner A; Woitkowiak C; Landsiedel R; van Ravenzwaay B
Toxicol In Vitro; 2010 Oct; 24(7):2030-40. PubMed ID: 20732407
[TBL] [Abstract][Full Text] [Related]
14. (Anti-)estrogenic and (anti-)androgenic effects in wastewater during advanced treatment: comparison of three in vitro bioassays.
Gehrmann L; Bielak H; Behr M; Itzel F; Lyko S; Simon A; Kunze G; Dopp E; Wagner M; Tuerk J
Environ Sci Pollut Res Int; 2018 Feb; 25(5):4094-4104. PubMed ID: 27397028
[TBL] [Abstract][Full Text] [Related]
15. Endocrine disrupting activities in sewage effluent and river water determined by chemical analysis and in vitro assay in the context of granular activated carbon upgrade.
Grover DP; Balaam J; Pacitto S; Readman JW; White S; Zhou JL
Chemosphere; 2011 Sep; 84(10):1512-20. PubMed ID: 21546050
[TBL] [Abstract][Full Text] [Related]
16. Impact of inorganic ions and pH variations on toxicity and endocrine potential of selected environmentally relevant pharmaceuticals.
Wieczerzak M; Kudłak B; Yotova G; Tsakovski S; Simeonov V; Namieśnik J
Environ Pollut; 2018 Jun; 237():549-558. PubMed ID: 29524877
[TBL] [Abstract][Full Text] [Related]
17. Assessing in-vitro estrogenic effects of currently-used flame retardants.
Krivoshiev BV; Dardenne F; Covaci A; Blust R; Husson SJ
Toxicol In Vitro; 2016 Jun; 33():153-62. PubMed ID: 26979758
[TBL] [Abstract][Full Text] [Related]
18. In vitro profiling of endocrine disrupting potency of 2,2',4,4'-tetrabromodiphenyl ether (BDE47) and related hydroxylated analogs (HO-PBDEs).
Liu H; Hu W; Sun H; Shen O; Wang X; Lam MH; Giesy JP; Zhang X; Yu H
Mar Pollut Bull; 2011; 63(5-12):287-96. PubMed ID: 21737105
[TBL] [Abstract][Full Text] [Related]
19. Estrogenic and androgenic activity of PCBs, their chlorinated metabolites and other endocrine disruptors estimated with two in vitro yeast assays.
Svobodová K; Placková M; Novotná V; Cajthaml T
Sci Total Environ; 2009 Nov; 407(22):5921-5. PubMed ID: 19716585
[TBL] [Abstract][Full Text] [Related]
20. Risk assessment and Biomonitoring Equivalent for 2-ethylhexyl-2,3,4,5 tetrabromobenzoate (TBB) and tetrabromobenzoic acid (TBBA).
Hays SM; Kirman CR
Regul Toxicol Pharmacol; 2017 Oct; 89():186-192. PubMed ID: 28751265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
